Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Clinical Research Units Hungary (“CRU Hungary”) has purchased the entire ALPHADAS® clinical trials software solution suite for a new Phase I facility being constructed in eastern Europe.
CRU Hungary is a privately owned hospital-based clinical research center that specializes in conducting outpatient and inpatient Phase II through IV clinical trials involving pharmaceutical, biological and medical device products. CRU Hungary serves sponsor companies and contract research organizations by conducting clinical studies within 5 different locations throughout Hungary.
“Beyond the comprehensive features and straightforward intuitive functionality, it was our visit to an ALPHADAS user site that cemented our decision to go with Instem Clinical,” comments Dr. Peter Kovacs at CRU Hungary. “Rather than a vendor, we were really looking to select a partner that could align with our mission of providing our clients with quality data and optimal study speed. The staff at Instem Clinical are true hands-on practitioners in our field, and they are poised to ensure that their ALPHADAS technology delivers superior results with high quality standards.”
About Clinical Research Units Hungary
Clinical Research Units Hungary (CRU Hungary Ltd.) is a privately owned Hospital-based Clinical Research Center that specializes in conducting outpatient and inpatient Phase II through IV clinical trials involving Pharmaceutical, Biological and Medical Device products.
More about CRU Hungary can be found at www.cruhungary.com
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com
CONSHOHOCKEN, Pa. -- (BUSINESS WIRE) --